221 related articles for article (PubMed ID: 1534179)
1. Chronic treatment with meta-chlorophenylpiperazine (m-CPP) alters behavioral and cerebral metabolic responses to the serotonin agonists m-CPP and quipazine but not 8-hydroxy-2(di-N-propylamino)tetralin.
Freo U; Holloway HW; Greig NH; Soncrant TT
Psychopharmacology (Berl); 1992; 107(1):30-8. PubMed ID: 1534179
[TBL] [Abstract][Full Text] [Related]
2. Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine.
Freo U; Merico A; Ermani M; Ori C
Brain Res; 2010 Jun; 1335():24-34. PubMed ID: 20381465
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent effects of buspirone on behavior and cerebral glucose metabolism in rats.
Freo U; Pietrini P; Pizzolato G; Furey-Kurkjian M; Merico A; Ruggero S; Dam M; Battistin L
Brain Res; 1995 Apr; 677(2):213-20. PubMed ID: 7552245
[TBL] [Abstract][Full Text] [Related]
4. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
Goodwin GM; Green AR
Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat.
Calogero AE; Bagdy G; Szemeredi K; Tartaglia ME; Gold PW; Chrousos GP
Endocrinology; 1990 Apr; 126(4):1888-94. PubMed ID: 2156670
[TBL] [Abstract][Full Text] [Related]
6. Cerebral metabolic responses to meta-chlorophenylpiperazine are reduced during its chronic administration to young and aged rats.
Freo U; Larson DM; Soncrant TT
Gerontology; 1993; 39(6):305-13. PubMed ID: 8144044
[TBL] [Abstract][Full Text] [Related]
7. Induction of purposeless chewing behaviour in rats by 5-HT agonist drugs.
Stewart BR; Jenner P; Marsden CD
Eur J Pharmacol; 1989 Mar; 162(1):101-7. PubMed ID: 2524394
[TBL] [Abstract][Full Text] [Related]
8. Time courses of behavioral and regional cerebral metabolic responses to different doses of meta-chlorophenylpiperazine in awake rats.
Freo U; Soncrant TT; Ricchieri GL; Wozniak KM; Larson DM; Rapoport SI
Brain Res; 1990 Mar; 511(2):209-16. PubMed ID: 2334843
[TBL] [Abstract][Full Text] [Related]
9. The pharmacology of the behavioural and hypothermic responses of rats to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
Goodwin GM; De Souza RJ; Green AR; Heal DJ
Psychopharmacology (Berl); 1987; 91(4):506-11. PubMed ID: 2954179
[TBL] [Abstract][Full Text] [Related]
10. 8-Hydroxy-2-(di-n-propylamino) tetralin is devoid of activity at the 5-hydroxytryptamine autoreceptor in rat brain. Implications for the proposed link between the autoreceptor and the [3H] 5-HT recognition site.
Middlemiss DN
Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):18-22. PubMed ID: 6238235
[TBL] [Abstract][Full Text] [Related]
11. The tricyclic antidepressant clomipramine dose-dependently reduces regional cerebral metabolic rates for glucose in awake rats.
Freo U; Pietrini P; Dam M; Pizzolato G; Battistin L
Psychopharmacology (Berl); 1993; 113(1):53-9. PubMed ID: 7862829
[TBL] [Abstract][Full Text] [Related]
12. Altered responses to serotonergic agents in Fawn-Hooded rats.
Gudelsky GA; Koenig JI; Meltzer HY
Pharmacol Biochem Behav; 1985 Mar; 22(3):489-92. PubMed ID: 3158004
[TBL] [Abstract][Full Text] [Related]
13. Parachloroamphetamine selectively alters regional cerebral metabolic responses to the serotonergic agonist metachlorophenylpiperazine in rats.
Freo U; Larson DM; Tolliver T; Rapoport SI; Soncrant TT
Brain Res; 1991 Mar; 544(1):17-25. PubMed ID: 1713115
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.
Björk L; Cornfield LJ; Nelson DL; Hillver SE; Andén NE; Lewander T; Hacksell U
J Pharmacol Exp Ther; 1991 Jul; 258(1):58-65. PubMed ID: 1830099
[TBL] [Abstract][Full Text] [Related]
15. The effects of 8-hydroxy-2-(di-n-propylamino)tetralin and other serotonergic agonists on performance in a radial maze: a possible role for 5-HT1A receptors in memory.
Winter JC; Petti DT
Pharmacol Biochem Behav; 1987 Aug; 27(4):625-8. PubMed ID: 2958885
[TBL] [Abstract][Full Text] [Related]
16. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
17. Beta-endorphin responses to different serotonin agonists: involvement of corticotropin-releasing hormone, vasopressin and direct pituitary action.
Bagdy G; Calogero AE; Szemeredi K; Gomez MT; Murphy DL; Chrousos GP; Gold PW
Brain Res; 1990 Dec; 537(1-2):227-32. PubMed ID: 2150776
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of the lordosis-inhibiting effects of 8-OH-DPAT by TFMPP and quipazine.
Wolf A; Jackson A; Price T; Trevino A; Caldarola-Pastuszka M; Uphouse L
Brain Res; 1998 Sep; 804(2):206-11. PubMed ID: 9757039
[TBL] [Abstract][Full Text] [Related]
19. 8-OH-DPAT and buspirone analogs inhibit the ketanserin-sensitive quipazine-induced head shake response in rats.
Yocca FD; Wright RN; Margraf RR; Eison AS
Pharmacol Biochem Behav; 1990 Jan; 35(1):251-4. PubMed ID: 2138331
[TBL] [Abstract][Full Text] [Related]
20. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
Chaouloff F; Jeanrenaud B
J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
